CH-53K Completes First Sea Trials

Image: U.S. Navy
Gemini Sparkle

Key Takeaways:

  • The U.S. Navy successfully completed the first two-week sea trials for the Sikorsky CH-53K King Stallion heavy lift helicopter aboard the USS Wasp amphibious assault ship.
  • During the trials, the CH-53K performed "extremely well" in various operations including launch, recovery, rotor start/shutdown, blade fold, and shipboard compatibility, day and night.
  • Featuring advanced systems, the CH-53K has previously completed other rigorous tests and is scheduled for initial operational testing in 2021, with its first fleet deployment expected by 2023-2024.
See a mistake? Contact us.

The U.S. Navy has announced the completion of the first sea trials of the Sikorsky CH-53K King Stallion heavy lift helicopter. According to the Navy, testing took place on the landing helicopter dock (LHD) amphibious assault ship USS Wasp. The two-week trials included launch and recovery operations, rotor start and shutdown, blade fold and shipboard compatibility testing.

“I’m very pleased with how the ship tests went,” said H-53 helicopters program manager Col. Jack Perrin. “We were able to assess the K taking off and landing day, night, and with night vision goggles and it performed extremely well.”

The GE T408-powered CH-53K features an integrated vehicle health monitoring system, glass cockpit and fly-by-wire controls. The aircraft successfully completed a 4.5-hour air-to-air refueling test in April and has previously completed high altitude, hot temperature, and degraded visual environment flights. The Navy expects to begin initial operational testing and evaluation of the CH-53K in 2021 followed by the first fleet deployment in 2023-2024.

Kate O'Connor

Kate is a private pilot, certificated aircraft dispatcher, and graduate of Embry-Riddle Aeronautical University.
Sign-up for newsletters & special offers!

Get the latest stories & special offers delivered directly to your inbox

SUBSCRIBE

Please support AVweb.

It looks like you’re using an ad blocker. Ads keep AVweb free and fund our reporting.
Please whitelist AVweb or continue with ads enabled.